Magnetic therapy pioneered by NUS researchers enhances chemotherapy treatment of breast cancer
- May 07, 2022
Photo credit: NUS
Have you heard about magnetic therapy for cancer treatment? This emerging therapy is currently being tested in a preliminary clinical trial for breast cancer by a research team led by iHealthtech Assoc Prof Alfredo Franco-Obregon and comprising researchers from iHealthtech and NUS Yong Loo Lin School of Medicine. The therapy employs a specially tuned magnetic field that is 1,000 times weaker in field strength than clinical magnetic resonance imaging (MRI) and applies it to, for example, an early-stage breast cancer patient using a unique engineered device, the OncoFTX System. Interestingly, the therapy will only have a detrimental effect on the cancer cell, not the healthy ones. The early clinical study aims to investigate the safety aspects of the new technique and will work alongside chemotherapy to eliminate cancer cells in subsequent clinical trials. To know more about how the research team found the cancer cell’s particular weakness and used the magnetic field to target it, please see the links below to the articles.
🌐 The Straits Times: NUS scientists develop painless way to shrink breast cancer using magnetic fields
🌐 NUHS Health Inside Out: Breakthrough therapy to complement breast cancer treatment
🌐 Frontiers in Oncology (Manuscript): Modulated TRPC1 Expression Predicts Sensitivity of Breast Cancer to Doxorubicin and Magnetic Field Therapy: Segue Towards a Precision Medicine Approach